HRT Financial’s VIVEVE MED INC VIVE Stock Holding History

HRT Financial’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,567	Closed	-$120K	–	3314
2020 Q4	$120K	Buy	+25,567	New	+$129K	﹤0.01%	1611

Other funds holding VIVE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HRT Financial's VIVE Position: Q1 2021 in Review

HRT Financial sold out of VIVEVE MED INC (VIVE) in Q1 2021, closing a stake of 25,567 shares — an estimated $120K sold.

HRT Financial first reported a position in VIVE in Q4 2020 and held it in 1 quarter. The position peaked at $120K in Q4 2020. 17 funds tracked by Wall St. Rank hold VIVE as of Q1 2021.

HRT Financial reported no remaining VIVEVE MED INC position as of Q1 2021 after selling out during the quarter.
HRT Financial sold 25,567 VIVEVE MED INC shares in Q1 2021, an estimated $120K.
HRT Financial first reported a position in VIVEVE MED INC in Q4 2020 and held it in 1 quarter.
HRT Financial's VIVEVE MED INC position peaked at $120K in Q4 2020.
17 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2021.

Based on HRT Financial's 13F filing for Q1 2021, filed 17 May 2021.